Literature DB >> 6790164

Identification of the major protein adduct formed in rat liver after thioacetamide administration.

M C Dyroff, R A Neal.   

Abstract

The in vivo covalent binding of the hepatocarcinogen thioacetamide to rat liver protein has been examined. Following administration of 3H- or 14C-labeled thioacetamide, the modified amino acids present in the hepatic cytosolic proteins were isolated by enzymatic digestion and ion-exchange chromatography. Approximately 70% of the radioactivity covalently bound to cytosolic protein was recovered in a compound which upon acid hydrolysis yielded lysine and radiolabeled acetate. Additional studies indicated the structure of this adduct was N-epsilon-acetyllysine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790164

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Covalent modification of lipids and proteins in rat hepatocytes and in vitro by thioacetamide metabolites.

Authors:  Diganta Sarma; Heather Hajovsky; Yakov M Koen; Nadezhda A Galeva; Todd D Williams; Jeffrey L Staudinger; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2012-06-15       Impact factor: 3.739

2.  The effect of thioacetamide on the activity and expression of cytosolic rat liver glutathione-S-transferase.

Authors:  B Spira; I Raw
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

3.  Epidermal growth factor reduces multiorgan failure induced by thioacetamide.

Authors:  M E Caballero; J Berlanga; D Ramirez; P Lopez-Saura; R Gozalez; D N Floyd; T Marchbank; R J Playford
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

4.  Single cell analysis in toxicity testing: the mitogenic activity of thioacetamide in cultured rat hepatocytes analyzed by DNA/protein flow cytometry.

Authors:  P Maier; H Schawalder; J Elsner
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  Protein targets of reactive metabolites of thiobenzamide in rat liver in vivo.

Authors:  Keisuke Ikehata; Tatyana G Duzhak; Nadezhda A Galeva; Tao Ji; Yakov M Koen; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2008-06-12       Impact factor: 3.739

6.  Influence of administration of long-chain polyunsaturated fatty acids on process of histological recovery in liver cirrhosis produced by oral intake of thioacetamide.

Authors:  I Fernández; I Torres; E Moreira; L Fontana; A Gil; A Rios
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

7.  Protein targets of thioacetamide metabolites in rat hepatocytes.

Authors:  Yakov M Koen; Diganta Sarma; Heather Hajovsky; Nadezhda A Galeva; Todd D Williams; Jeffrey L Staudinger; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2013-03-20       Impact factor: 3.739

8.  Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models.

Authors:  Pavel Strnad; Guo-Zhong Tao; Qin Zhou; Masaru Harada; Diana M Toivola; Elizabeth M Brunt; M Bishr Omary
Journal:  Gastroenterology       Date:  2008-01-18       Impact factor: 22.682

9.  Metabolism of thioamides by Ralstonia pickettii TA.

Authors:  Anthony G Dodge; Jack E Richman; Gilbert Johnson; Lawrence P Wackett
Journal:  Appl Environ Microbiol       Date:  2006-09-22       Impact factor: 4.792

10.  Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity.

Authors:  R S Mangipudy; P S Rao; H M Mehendale
Journal:  Environ Health Perspect       Date:  1996-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.